David Yi

Partner
Norton Rose Fulbright Canada LLP
david.yi@nortonrosefulbright.com
David
Yi
David Yi
Toronto
222 Bay Street, Suite 3000, P.O. Box 53
Toronto
Ontario
M5K 1E7
Canada
+1 416 202 6724

David Yi is the Toronto local chair of our intellectual property group. He is a commercial litigator focused on complex, high‑stakes, intellectual property and technology‑centric disputes.

David represents clients in all manner of disputes involving patents, copyright, industrial designs, trademarks, breaches of contracts involving IP, software, and licensing agreements, competition class actions, and complex financial damages disputes. He has represented a broad range of clients including multi-nationals, small and mid-cap business, SMEs, and high-profile influencers. David is experienced in an array of technologies from the pharmaceutical, cannabis, medical device, financial services, information technology, software, retail, energy, infrastructure, and automotive sectors.

David clerked at the Federal Court for the Honourable Mr. Justice Zinn and holds a J.D. from the University of Toronto and an Honours Bachelor of Health Sciences from McMaster University. He is active in the IP community, including by judging and mentoring for the Harold G. Fox IP Moot, speaking on IPIC panels and at U of T's Patent Colloquium, and collaborating with IP Ontario. He is committed to access to justice and regularly volunteers with Pro Bono Law Ontario and the Canadian Centre for Housing Rights.

Representative experience

David has acted in the following matters:

  • Co-counsel on a patent infringement/impeachment action relating to automotive products.
  • Represented defendant in successfully obtaining summary dismissal of claims under the Ontario and UK Statute of Monopolies.
  • Represented defendants in eight different actions for damages brought under section 8 of the Patented Medicines (Notice of Compliance) Regulations.
  • Represented defendant in a patent impeachment action related to drugs for treating anemia.
  • Represented patentee on applications brought under the  Patented Medicines (Notice of Compliance) Regulations  in connection with a patented invention for a drug used for preventing and treating osteoporosis.
  • Defended pharmaceutical company in dismissing multi-defendant class action relating to drug pricing.
  • Lead counsel for large retailers in many patent and industrial design matters.

Awards and recognitions

  • IAM Patent 1000, Recommended Individual: Litigation, Law Business Research Ltd., 2024-2025
  • Managing IP, IP Stars, 2023-2025: Notable Practitioner

Education

J.D., University of Toronto, 2012
B.H.Sc.(Hons.), McMaster University, 2009

Admissions

  • Ontario 2013

Speaking engagements

  • Summary Judgement: When and how to Use it Effectively for Patent Matters? 14th Annual University of Toronto Patent Colloquium, November 14, 2025
  • Best Practices in Cross-Border IP Litigation, IPIC Annual Conference, October 10, 2025
  • Induced Infringement - Is "Skinny Labelling" a Thing of the Past, IPIC Annual Conference, September 26, 2024
  • Year-in-Review in IP Law 2023 - PATENT LAW, IPIC, February 13, 2024
  • Protecting Confidential Information, IPIC, June 27, 2023

Publications

Further publications can be found below under “Insights.”

Membership and activities

  • Canadian Bar Association
  • Ontario Bar Association
  • Toronto Intellectual Property Group
Bio